PeterCPhillipsMD

Pediatric Hematology & Oncology • Philadelphia, PA

Pediatric Neuro-Oncology, Pediatric Solid Tumor Oncology

Professor of Neurology, University Pennsylvania

Join to view full profile

Dr. Phillips is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Phillips' full profile

Already have an account?

Office
3401 Civic Center Blvd
Children's Hospital Of Philadelphia - Hem/Onc
Philadelphia, PA 19104
Phone+1 215-590-2299

Fax+1 215-590-3296

Education & Training

New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 1985 - 1986
New York Presbyterian Hospital (Cornell Campus)Fellowship, Child Neurology, 1983 - 1985
New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 1981 - 1982
Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1978 - 1980
Uconn School Of MedicineClass of 1978

Certifications & Licensure

NY State Medical License 1980 - Present
PA State Medical License 1991 - 2024
FL State Medical License 2013 - 2015
MD State Medical License 1986 - 1991
American Board of Pediatrics Pediatrics
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2008-2014
Philadelphia Magazine Castle Connolly, 2005-2007, 2009-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Low-Dose Radiation and Combination Chemotherapy Following Surgery in Children With Newly Diagnosed Medulloblastoma Start of enrollment: 2001 Apr 01
Terminated
Phase 2
Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System Start of enrollment: 2009 Feb 25
Completed
Phase 1
Vismodegib in Treating Patients With Recurrent or Refractory Medulloblastoma Start of enrollment: 2009 Jun 01
Completed
Phase 2
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma Start of enrollment: 2010 Apr 19
Active, not recruiting
Phase 1, Phase 2
Biomarkers in Blood Samples From Young Patients With Newly Diagnosed Brain Tumors Undergoing Standard Radiation Therapy and Chemotherapy Start of enrollment: 2010 May 01
Withdrawn
Not Applicable
Vismodegib in Treating Younger Patients With Recurrent or Refractory Medulloblastoma Start of enrollment: 2010 Nov 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

431 citations
Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas
Roger J. Packer, Joann L. Ater, Jeffrey C. Allen, Peter C. Phillips, Russell Geyer
Journal of Neurosurgery. 1997-05-01
143 citations
MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma.
Michael A. Grotzer, Michael D. Hogarty, Anna J. Janss, Xueyuan Liu, Huaquing Zhao
Clinical Cancer Research. 2001-08-01
17 citations
Risk of brainstem necrosis in pediatric patients with central nervous system malignancies after pencil beam scanning proton therapy
J. Vogel, A. Grewal, Shannon O'Reilly, Robert A. Lustig, G. Kurtz
Acta Oncologica. 2019-09-12